TY - JOUR
T1 - Treatment of atenolol overdose in a patient with renal failure using serial hemodialysis and hemoperfusion and associated echocardiographic findings
AU - Salhanick, Steven D.
AU - Wax, Paul M.
PY - 2000/8/1
Y1 - 2000/8/1
N2 - A 28-y-old male with end stage renal failure (ESRF) received an overdose of atenolol. Subsequent cardiac arrest and prolonged cardiogenic shock required aggressive pharmacologic support, intraaortic balloon pump insertion, and mechanical ventilation. Four hemodialyses with charcoal hemoperfusion were performed over 72 h. Plasma atenolol levels decreased from 7.4 mg/L to 2.1 mg/L although significant rebound occurred between dialyses. Transthoracic echocardiogram showed global hypokinesis with an ejection fraction (EF) of 5-10% prior to cardiac arrest, compared to baseline and following EF's of approximately 35%. Our experience supports hemodialysis for ESRF patients with atenolol toxicity.
AB - A 28-y-old male with end stage renal failure (ESRF) received an overdose of atenolol. Subsequent cardiac arrest and prolonged cardiogenic shock required aggressive pharmacologic support, intraaortic balloon pump insertion, and mechanical ventilation. Four hemodialyses with charcoal hemoperfusion were performed over 72 h. Plasma atenolol levels decreased from 7.4 mg/L to 2.1 mg/L although significant rebound occurred between dialyses. Transthoracic echocardiogram showed global hypokinesis with an ejection fraction (EF) of 5-10% prior to cardiac arrest, compared to baseline and following EF's of approximately 35%. Our experience supports hemodialysis for ESRF patients with atenolol toxicity.
UR - http://www.scopus.com/inward/record.url?scp=0033931060&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0033931060&partnerID=8YFLogxK
M3 - Article
C2 - 10928688
AN - SCOPUS:0033931060
SN - 0145-6296
VL - 42
SP - 224
EP - 225
JO - Veterinary and Human Toxicology
JF - Veterinary and Human Toxicology
IS - 4
ER -